Cover Image
Market Research Report

Immunoassay Systems

Published by Global Industry Analysts, Inc. Product code 243078
Published Content info 334 Pages
Delivery time: 1-2 business days
Price
Back to Top
Immunoassay Systems
Published: March 1, 2017 Content info: 334 Pages
Description

This report analyzes the worldwide markets for Immunoassay Systems in US$ Thousand by the following Technology Segments: Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 65 companies including many key and niche players such as -

Abbott Laboratories
Beckman Coulter, Inc.
bioMerieux SA
Bio-Rad Laboratories Inc.
DiaSorin S.p.A

Table of Contents
Product Code: MCP-3522

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Enzyme Immunoassay
    • Fluorescence Immunoassay
    • Chemiluminescence Immunoassay
    • Rapid Tests
    • Elispot
    • Others

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Immunoassays - A Preface
  • Current and Future Analysis
  • Factors Sustaining Market Growth
  • Factors Restraining Growth
  • Developing Markets to Drive Sales
  • Radioimmunoassay Systems Lose Ground
  • Chemiluminescence Immunoassays Gain Demand
  • Expanding Immunoassay Applications Boost Demand
    • Table 1: Global Laboratory Based Immunoassay Market (2016): Percentage Share Breakdown of Value Sales by Clinical Area (includes corresponding Graph/Chart)

2. COMPETITIVE LANDSCAPE

    • Table 2: Leading Players in the Global Immunoassay Systems Market (2015) - Percentage Share Breakdown of Sales by Company (includes corresponding Graph/Chart)

3. MARKET TRENDS AND ISSUES

  • Bespoke Solutions Energize Market Growth
  • Multiplex Immunoassays Grow in Demand
  • Novel Biomarkers to Boost Market Growth
  • SERS - An Attractive Readout Strategy
  • Automated Immunoassay Systems - In Line with Automation Trend
  • Technological Advances to buoy ELISA's Prospects
  • Automation of ELISA - Enabling its Sustenance
  • Growing Popularity of Multiplexing Deters ELISA Market
  • Commoditization: A Key Issue Facing ELISA Product Manufacturers
  • Consolidation of Hospitals and Labs Drives Demand
  • POC and DIA Systems Grow in Demand
  • Prenatal Testing - An Opportunity Market
  • Rise in Infectious Diseases Raises Demand
  • Increasing Use of Immunoassays in Food Sciences and Quality Control
  • Growing Use in Environmental Testing

4. MACRO GROWTH DRIVERS AND APPLICATION MARKETS

  • Improving Healthcare Expenditure to Foster Growth
    • Table 3: Healthcare Spending as % of GDP by Region (2017E) (includes corresponding Graph/Chart)
  • Aging Global Population Buoys Market Growth
    • Table 4: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
  • Infectious Disease Diagnosis: The Largest Application Area
  • Increasing Incidence of Infectious Diseases - An Opportunity Indicator
    • Table 5: Reported Cases of Major Infections by Select Geographic Region: 2011
  • Endocrine Testing Procedures
  • Growing Diabetes Prevalence Boost Prospects for Immunoassay-based HbA1c Tests
    • Table 6: Worldwide Prevalence of Diabetes Mellitus by Region (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 7: Incidence of Diabetes in Select Countries (2015 & 2040) (includes corresponding Graph/Chart)
  • Blood Processing Market
  • Cancer Testing Markets
  • Drugs of Abuse Testing Market
  • Therapeutic Drug Monitoring
  • Immune Disease
  • Blood Grouping and Typing

5. CONCEPTUAL OVERVIEW

  • Immunoassays - Definition and Description....
  • Down the Timeline
  • Immunoassay Analyzers
  • Immunoassay Reagents
  • Components of Immunoassays
  • Signal Response
  • Labeled Tracer
  • Binder
  • Buffer Matrix
  • Incubation Conditions
  • Separation Process
  • Standard Specimens
  • Control Specimens
  • Unknown Specimens
  • Types of Immunoassay Analyzers
  • An Insight Into Immunoassay Technologies
  • Enzyme Immunoassays (EIA)
  • ELISA - A Renowned and Proven Assay Format
  • Fluorescence Immunoassay - Operating Principle
  • Chemiluminescence Immunoassay
  • Radioimmunoassay Analyzers, Gamma Counters
  • Rapid Tests
  • ELISPOT
  • Western Blot
    • Comparison of Various Immunoassay Technologies
  • Purchase Considerations for Analyzers

6. PRODUCT LAUNCHES/APPROVALS

  • Sekisui Diagnostics Launches new SEKURE(r) TPLA and RPR Assays for Syphilis Testing
  • Siemens Healthineers Introduces Atellica Solution automated Immunoassay Analyzer System
  • Abbott Introduces Alinity(tm)
  • Roche Introduces New Cobas e 801 Module
  • Siemens to Release Genetic Assay for Detection of Zika Virus
  • Fujirebio Europe Releases the Lumipulse G B*R*A*H*M*S PCT Assay
  • Fujirebio Releases "Lumipulse L 2400" CLIA System
  • Roche Introduces Elecsys(r) HTLV-I/II Immunoassay
  • Siemens Introduces ADVIA Centaur Syphilis Assay
  • Sysmex Introduces HISCL-800 Automated Immunoassay System
  • Siemens Introduces New Chemistry & Immunoassay Systems
  • Meso Scale Discovery Launches S-PLEX(tm) Assays
  • Modern Water Monitoring Introduces New Immunoassay Strip Test and Readers
  • Enzo Life Sciences Launches Amp'd(tm) ELISA Signal Amplification Kit
  • EMD Millipore Rolls Out New Immunoassay Kits
  • PerkinElmer Launches Novel Research Tools
  • Roche Releases Elecsys Syphilis Immunoassay

7. RECENT INDUSTRY ACTIVITY

  • Abbott Receives CE Mark for Alinity CI-Series Diagnostic Systems
  • Quidel Receives FDA Clearance for New Solana(R) Molecular Assay
  • Quidel Receives FDA Clearance for Solana(R) Strep Complete Assay
  • FDA Clears ORTHO VISION(r) Max Analyzer for High-Volume Transfusion Medicine Labs
  • Beckman Coulter Receives FDA Clearance for Access TSH (3rd IS) Assay
  • Quidel Receives FDA Clearance for Solana(R) Influenza A+B Assay
  • Ortho Clinical Diagnostics Receives CE Mark Approval for VITROS(r) Immunodiagnostic HIV Combo Test
  • Siemens Healthcare Changes Name to Siemens Healthineers
  • DiaSorin to Acquire Focus Diagnostics' Molecular and Immunoassay Product Business
  • Quidel Receives CE Mark for Quidel's Sofia(r) S. pneumoniae Fluorescent Immunoassay
  • DiaSorin and Beckman Coulter Sign Agreement to Distribute Hepatitis and HIV Tests in China
  • bioMerieux Receives FDA 510(k) clearance for VIDAS(r) 3
  • Quidel Receives FDA Clearance for New Solana(tm) Molecular System and Solana(tm) Molecular Assay
  • Siemens Receives FDA Approval for Siemens HIV Combo assay
  • Eurofins Acquired ViraCor-IBT Laboratories
  • YSL Bio Signs Enters into Agreement with GeneX
  • Techne to Acquire CyVek
  • Gyros Enters into Distribution Agreement with Tekon Biotech
  • Singulex Partners with Tecan
  • OriGene Technologies Takes Over BioCheck
  • Techne Partners with Fisher Scientific

8. FOCUS ON SELECT MARKET PARTICIPANTS

  • Abbott Laboratories (USA)
  • Beckman Coulter, Inc. (USA)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories Inc. (USA)
  • DiaSorin S.p.A (Italy)
  • Fujirebio, Inc. (Japan)
  • Ortho-Clinical Diagnostics, Inc. (USA)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (USA)
  • Sysmex Corporation (Japan)
  • Quidel Corporation (USA)
  • Tosoh Bioscience, Inc. (USA)

9. GLOBAL MARKET PERSPECTIVE

    • Table 8: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 9: World Historic Review for Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 10: World 14-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
  • Immunoassay Market by Technology
    • Table 11: World Recent Past, Current & Future Analysis for Enzyme Immunoassay by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 12: World Historic Review for Enzyme Immunoassay by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 13: World 14-Year Perspective for Enzyme Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 14: World Recent Past, Current & Future Analysis for Fluorescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Fluorescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 16: World 14-Year Perspective for Fluorescence Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 17: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 18: World Historic Review for Chemiluminescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 19: World 14-Year Perspective for Chemiluminescence Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 20: World Recent Past, Current & Future Analysis for Rapid Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 21: World Historic Review for Rapid Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 22: World 14-Year Perspective for Rapid Tests by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 23: World Recent Past, Current & Future Analysis for ELISPOT by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for ELISPOT by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 25: World 14-Year Perspective for ELISPOT by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 26: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 27: World Historic Review for Polymerase Chain Reaction (PCR) Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 28: World 14-Year Perspective for Polymerase Chain Reaction (PCR) Technology by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 29: World Recent Past, Current & Future Analysis for Other Immunoassays by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 30: World Historic Review for Other Immunoassays by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 31: World 14-Year Perspective for Other Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
      • Increasing Burden of Chronic Diseases Drives Focus onto Immunoassays
      • An Overview of ELISA Usage
      • Ageing Demographics: Major Driving Factor
    • Table 32: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Product Launches/Approvals
    • Strategic Corporate Developments
    • Focus on Select Players
  • B. Market Analytics
    • Table 33: US Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 34: US Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 35: US 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 36: Canadian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 37: Canadian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 38: Canadian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Product Launches
    • Focus on Key Players
  • B. Market Analytics
    • Table 39: Japanese Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 40: Japanese Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 41: Japanese 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
      • Automation Supports Growth in Western European IVD Market
      • Immunochemistry Analyzer Market
    • Recent Industry Activity
  • B. Market Analytics
    • Table 42: European Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - France, Germany, Italy, the UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 43: European Historic Review for Immunoassay Systems by Geographic Region - France, Germany, Italy, the UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 44: European 14-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, the UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 45: European Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 46: European Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 47: European 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Biomerieux - A Key Player
  • B. Market Analytics
    • Table 48: French Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 49: French Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 50: French 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launches
  • B. Market Analytics
    • Table 51: German Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 52: German Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 53: German 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Diasorin S.p.A - A Key Player
  • B. Market Analytics
    • Table 54: Italian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 55: Italian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 56: Italian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launch
  • B. Market Analytics
    • Table 57: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 58: UK Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 59: UK 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 60: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 61: Spain Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 62: Spain 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 63: Russian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 64: Russian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 65: Russian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
    • Roche Diagnostics - A Key Player
  • B. Market Analytics
    • Table 66: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 67: Rest of Europe Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 68: Rest of Europe 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
      • Growing In-Vitro Diagnostics (IVD) Market Fuels Demand for Immunoassay Instruments
  • B. Market Analytics
    • Table 69: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 70: Asia-Pacific Historic Review for Immunoassay Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 71: Asia-Pacific 14-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 72: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 73: Asia-Pacific Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 74: Asia-Pacific 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Current and Future Analysis
      • In-Vitro Diagnostics Market
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 75: Chinese Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 76: Chinese Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 77: Chinese 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Current and Future Analysis
      • Immunoassay Systems market - An Overview
      • Emerging Trends...
  • B. Market Analytics
    • Table 78: Indian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 79: Indian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 80: Indian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
      • Indonesia
      • Malaysia
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 81: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 82: Rest of Asia-Pacific Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 83: Rest of Asia-Pacific 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 84: Latin American Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 85: Latin American Historic Review for Immunoassay Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 86: Latin American 14-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin American Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 87: Latin American Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 88: Latin American Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 89: Latin American 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6a. BRAZIL

  • Market Analysis
    • Table 90: Brazilian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 91: Brazilian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 92: Brazilian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 93: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 94: Rest of Latin America Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 95: Rest of Latin America 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analysis
    • Table 96: Rest of World Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 97: Rest of World Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 98: Rest of World 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top